will break the barrier, making the TJ a frequent contributor to a vast range of pathologies of blood vessels and epithelial organs. Since most of these insults have pleotropic cellular effects, it is difficult to envision therapies that could target specific TJ components or functions. In contrast, some assaults on the barrier are quite specific. For example, house dust mites excrete a fecal protease that cleaves occludin and claudin, loosens the barrier and in theory allows allergens to cross the airway and skin epithelia. Similarly, some types of allergenic pollen produce a protease which cleaves occludin, enhancing allergen entry. Specific claudins are receptors for a cytotoxic diarrheainducing enterotoxin produced by Clostridium perfringens and other claudins are co-receptors required for hepatitis C virus to enter cells.
The growing list of diseases caused by mutations in the genes encoding TJ proteins has provided significant insight into how the TJ works. For example, claudins 16 and 19 form cation-selective pores and are located in a segment of the kidney tubule where Mg 2+ ions return to the body by passing through the TJ. Mutations in either protein are associated with a failure to reabsorb Mg 2+ , leading to low serum Mg 2+ levels and resultant weakness and seizures. Loss of ion selectivity may also explain why claudin-14 mutations lead to deafness. Mutations in PMP-22, a claudin which seals myelin, lead to peripheral neuropathies through an unknown mechanism. Hopefully our increasing knowledge of TJ structure will lead to specific therapies to preserve or restore integrity of the barrier.
Can we manipulate TJs to enhance drug delivery?
In principle it might be desirable to open TJs in order to enhance drug delivery across epithelia like the gut and airway surfaces or across blood vessels like the bloodbrain barrier. Manipulation of the barrier may be required for the delivery of emerging therapeutic agents based on peptides, proteins and DNA. Despite wide interest and research, however, no agents have yet reached clinical application. Early efforts employed non-specific attacks on general signaling pathways that led to cells being pulled apart or alternatively used detergents to disrupt epithelial integrity. More recent approaches specifically target the intercellular interactions of claudins or occludin. Given the role of TJs in limiting drug delivery, there is a lot of creative energy applied to this problem; however, we will have to wait to see whether it's a good idea to break the barrier even transiently. While the Wnt-β-catenin pathway is often thought of as a major signaling pathway in animal development, it also plays important roles in stem cell maintenance in regenerating tissues such as intestinal epithelia and hair follicles. Wnt-β-catenin signaling Primer can also promote appendage regeneration and wound repair. This may reflect an ancient role for Wnts, as pathway activation is required for regeneration of the head organizer of hydra, a freshwater cnidarian. In addition to its essential functions in development and tissue homeostasis, misregulation of Wnt-β-catenin signaling has been implicated in several pathological states. Constitutive activation of the pathway has been linked to several human cancers. Wnt-β-catenin signaling in vertebrates promotes bone disposition, and mutations that reduce signaling can result in fragile bones. This pathway has also been implicated in other diseases such as heart disease and Alzheimer's, though further validation of these reports is needed. This primer provides an overview of how Wnts are released from producing cells and how they signal from the cell surface to the nucleus of receiving cells.
Is there a link between

Wnt secretion and extracellular movement
Wnts contain signal sequences at their amino-termini that target them to the endomembrane/ secretory compartment. Like many secreted proteins, they are subject to amino-linked glycosylation in the endoplasmic reticulum (ER). Furthermore, many Wnts have been shown to be palmitoylated at the first conserved cysteine; palmitoylic acid can also be covalently linked to a conserved serine in some Wnts. The function of Wnt lipidation is somewhat controversial, though this is likely due to differences in the chosen Wnt and species, and the methodology used to study them. In cell culture, Wnts lacking cysteine Wnt is palmitoylated by the Porc acyltransferase, which may facilitate its exit from the ER. In the trans-Golgi, Wls directs Wnt to the cell surface where it can associate with extracellular molecules such as glypicans or lipoproteins. Wls recycling back to the Golgi requires the retromer complex; in the absence of Retromer, Wls is missorted to the lysosomes and degraded. palmitolyation are secreted but not functional, while in fly embryos a corresponding mutation of the Wingless gene causes a block in secretion of the encoded protein and likely accumulation in the ER. Consistent with these results, mutations in the porcupine (porc) gene, which encodes an integral membrane acyltransferase localized to the ER, blocks secretion of Wg. This suggests a model in which modification by Porc is required for export of Wnt from the ER (Figure 1 ). In the case of palmitoleic acid, prevention of the modification inhibits either secretion or signaling activity of Wnt, depending on the system and Wnt tested.
After post-translational modification, several Wnts require an integral membrane protein called Wntless (Wls) for secretion. Wls is localized to the Golgi, cell surface and endosomes and appears to be dedicated to Wnt secretion. Wls can directly associate with Wnt, suggesting that it acts to guide Wnt from the Golgi to the cell surface. Recycling of Wls from the plasma membrane requires the activity of the retromer complex: mutation of retromer subunits results in reduced levels of Wls protein and Wnt signaling as a result of mistrafficking of Wls to the lysosome (Figure 1) .
Given the complexity of Wnt modification and secretion, it is not surprising that large quantities of biologically active, soluble Wnt have been so notoriously difficult to obtain through standard expression in cultured cells. It would also not be surprising to find that the efficiency of Wnt secretion and/or activity is being modulated by regulation of acyltransferase and/or Wls activity. That said, this system may not be required for the entire Wnt family, as a recent report found that one fly Wnt is not lipidated and does not require either porc or Wls for secretion and activity.
Once outside of the producing cell, Wnts become associated with the surface of cells and the extracellular matrix. Glypicans, one type of cell surface proteoglycan, are required for Wnt signaling in fly tissues. Glypicans are known to act as co-receptors in FGF signaling and there is evidence supporting a similar role in Wnt signaling. Glypicans also promote the spread of Wnt through a developing tissue. Wnts can act as morphogens, directly regulating distinct target genes in a concentration-dependent manner, and glypicans can profoundly influence the shape of the Wnt morphogen gradient. In fly tissues, extracellular Wnts can also associate with lipoprotein complexes that facilitate their diffusion (Figure 1 ).
Wnt-induced stabilization of β-catenin
The Wnt-β-catenin pathway revolves around the stability of β-catenin, with higher levels of this protein promoting activation of Wnt targets. β-catenin is also essential for cell adhesion, forming a link between E-cadherin and the actin cytoskeleton. In addition to this membrane-bound pool of β-catenin, there is a cytoplasmic pool that rapidly turns over in unstimulated cells. It is this β-catenin pool that is regulated by Wnt stimulation, although there is evidence for a more dynamic interaction between cytosolic and membrane-bound β-catenin in some cells, suggesting a direct link between Wnt-β-catenin signaling and cell adhesion.
Degradation of β-catenin is triggered by a dual kinase mechanism, where phosphorylation of a particular serine by casein kinase I (CKI) leads to phosphorylation of several other serine/threonines by glycogen synthase kinase 3 (GSK3). This modified β-catenin is then bound by the F-box-containing ubiquitin E3 ligase β-TrCP, triggering poly-ubiquitination and proteosomal degradation of β-catenin ( Figure 2A) . As a result, β-catenin not bound to cadherin has an average half-life of approximately 30 minutes in the cell.
For β-catenin to be phosphorylated by CKI and GSK3, it must be bound by a complex containing two other factors, the adenomatous polyposis coli (APC) protein and Axin (Figure 2A) . These large proteins appear to act as scaffolds, positioning β-catenin and the kinases to allow efficient phosphorylation. These proteins cycle between the cytoplasmic and nuclear compartments and act to prevent accumulation of β-catenin in the nucleus. The associated APC-Axin-CKI-GSK3 proteins are often referred to as the β-catenin destruction complex. Consistent with the proposed role of the destruction complex, mutation of either APC or Axin results in dramatically elevated levels of β-catenin in both the cytoplasm and nucleus. A similar effect is observed when the CKI or GSK3 phosphorylation sites in β-catenin are mutated.
The study of β-catenin turnover is a prime example of the interplay between clinical and basic research. The APC gene was first identified as the target for a familial form of colorectal cancer: sporadic mutation of APC activity occurs in approximately 90% of all human colorectal cancers. After APC function was linked to β-catenin turnover, studying this process in model systems -Xenopus and Drosophila -revealed that CKI and GSK3 phosphorylate the aminoterminus of β-catenin. Examination of colorectal cancers with wild-type APC genes revealed that many have mutations in the CKI or GSK3 phosphorylation sites of β-catenin: up to 20% of all human cancers contain these specific mutations. Our basic understanding of Wnt-β-catenin signaling has been advanced by the study of a particular human cancer, while a deeper understanding of the biochemical mechanism has led to the recognition that this pathway plays a major role in many human cancers. For cells to stabilize β-catenin in response to extracellular Wnt protein, they must have specific cell surface receptors that can bind to Wnt with high affinity as well as transduce the signal across the cell membrane. While the number of identified potential Wnt receptors is growing, it is also clear that most Wnt-β-catenin signaling occurs through an unlikely pairing of members of two distinct receptor families: Frizzleds (Fzs) and two members of the lipoprotein receptor related protein (LRP) family, LRP5 and LRP6. Fzs are members of the larger family of seven-membrane spanning G-protein-coupled receptors that mediate a wide variety of signaling events; this family includes the olfactory receptors, for example. LRPs include the low density lipoprotein receptor. The current model is that the Wnt ligand promotes association of Fz and LRP5/6, and this close association leads to activation of the receptor complex.
Wnt-dependent coupling of Fz and LRP5/6 is reminiscent of the ligand-induced dimerization and subsequent trans-phosphorylation that occurs with tyrosine kinase or TGF-β receptors, except that neither Fz or LRP5/6 has any known enzymatic activity. Wnt binding does, however, induce phosphorylation of the cytoplasmic tail of LRP5/6, and this modification is required for β-catenin stabilization. Interestingly, this phosphorylation of LRP is mediated by CKI and GSK3, the same kinases that act in the destruction complex to target β-catenin for degradation. There is some debate about which specific CKI family members act on LRP and β-catenin, but the CKI-GSK dual phosphorylation mechanism has both a positive (LRP) and negative (β-catenin) effect on Wnt signaling.
The exact details of receptor complex activation and LRP phosphorylation are still under investigation, but it appears that several factors act in a mutallydependent manner to facilitate the process. LRP phosphorylation requires the co-receptor Fz, which is bound by PDZ-containing proteins called Dishevelleds (Dvls) upon Wnt stimulation. Dvls promote LRP phosphorylation and Axin recruitment to the plasma membrane. However, Axin recruitment is not sequential to these events, because this protein is also required for LRP phosphorylation. These data suggest a model in which these factors all contribute to the formation of an active-LRP phosphorylated complex. Indeed, there is also compelling evidence that LRP and Dvl form higher-order complexes upon Wnt stimulation, suggesting the existence of an even larger Wnt signalosome at the cell surface ( Figure 2B ).
The recruitment of Axin to the phosphorylated tail of LRP5/6 may promote β-catenin stabilization by compromising the activity of the destruction complex as well as promoting Axin degradation. But this may not be the whole story. Consistent with Fzs being members of the G-protein coupled receptor superfamily, Gαo and Gαq subunits are required for Wnt-β-catenin signaling, and locking these proteins in the GTP-bound state promotes pathway activation. However, direct evidence for a physical link between Fz and Gαo/q is lacking and the target(s) of the activated G-protein is still mysterious, though Dvls are attractive candidates perhaps by promoting their phosphorylation (Figure 2) .
The Wnt-β-catenin pathway is a prime example of how regulation of protein turnover can modulate cell signaling. By relying on stabilization of β-catenin, this branch of Wnt signaling by necessity acts over the course of hours, as opposed to minutes. This is in contrast to pathways that do not require new protein synthesis to operate. Thus, the Wnt-β-catenin pathway is very often found in contexts such as cell-fate determination and tissue homeostasis, as opposed to situations where more immediate regulation of gene expression is required, for example stress responses.
A transcriptional switch
After stabilization, β-catenin translocates across the nuclear pore complex to the nucleoplasm. It is thought that this is an intrinsic property of β-catenin, although there are several factors that can influence its nuclear import or export. Once in the nucleus, β-catenin can act as a transcriptional co-regulator, binding to specific DNA-binding transcription factors. Although the list of proteins known to recruit β-catenin to target genes is growing -Foxo, PitX2, SOX9 and SOX17, for examplemost cases of Wnt-mediated transcriptional regulation involve members of the TCF protein family.
While the interaction of β-catenin and TCF is critical for activation of Wnt targets, it is also critical that these targets are not activated inappropriately by small amounts of nuclear β-catenin. Several different factors have been identified that act as nuclear β-catenin buffers -they compete with the β-catenin-TCF interaction by binding to either factor. ICAT, Chibby, Sox9 and CtBP-APC are among the factors that bind to β-catenin and inhibit it binding to TCF. Members of the TLE/Gro family do the same for TCFs ( Figure  3A ). These nuclear factors raise the threshold of nuclear β-catenin required for its recruitment to Wnt targets via binding to TCF.
In the absence of signaling, many Wnt targets are silenced by TCF-mediated repression. This occurs in part through TCF binding to TLE/Gro, which in turn recruits histone deacetylases ( Figure 3A ). Other factors have also been implicated in silencing Wnt targets -for example, Kaiso and the chromatin remodeling complex ACF -though these act in parallel to TCF-TLE/Gro and do not function on all targets.
When β-catenin reaches levels sufficient to bind to TCF, this interaction displaces TLE/Gro from Wnt target genes, relieving repression. In addition, β-catenin serves as a landing platform for a variety of transcriptional co-activators. These include Legless/Bcl9 and Pygopus (Pygo) which bind to the amino-terminal half of β-catenin, while the histone acetyl transferase CBP and Parafibromin/ Hyrax bind to the carboxy-terminal portion. There are many other co-activators that bind to β-catenin and promote its ability to activate Wnt target genes; however, many of these factors are likely to be gene, cell-type or species-specific. Indeed, while pygo is essential for Wnt regulation of targets in flies, mice lacking both pygo genes have a much more modest reduction in Wnt target gene expression. At the general level, however, the idea that β-catenin switches a TCF from a transcriptional repressor to an activator is a useful way to think of Wnt-mediated regulation of many target genes. While invertebrate TCFs clearly contain both the repressive and activating activitiesessential in flies and worms which only have one TCF each -it appears that some vertebrate TCFs have become more specialized, with TCF3 possessing mainly silencing activity and LEF1 functioning in the activation portion of the transcriptional switch.
It should be noted that there are many genes that are downregulated in response to Wnt signaling, and in some cases it has been confirmed that a TCF-β-catenin complex directly mediates this repression. How many of the genes downregulated by Wnt-β-catenin signaling are directly repressed remains an important unanswered question. The mechanism of TCF-β-catenin repression has not been worked out in detail, and it appears to be different among the few genes studied in detail. The diversity of mechanisms by which β-catenin can regulate gene expression likely explains how this pathway can perform so many essential functions throughout the animal kingdom. In the absence of signaling (A), TCF represses Wnt targets by recruiting co-repressors such as TLE/Gro. Other repressive complexes also contribute to this silencing. In addition, there are several factors that act as 'nuclear β-catenin buffers' which prevent β-catenin-TCF interaction when β-catenin is present at low concentrations. On Wnt signaling (B), the high level of nuclear β-catenin overcomes these buffers, and β-catenin displaces the repressors from the target gene chromatin. β-catenin dependent recruitment of a variety of co-activators allows transcription to proceed. The perceived position of a moving object depends on the object's motion and the motion of other objects in the scene [1] . Here, we report a real-world example of how this causes a perceptual error for professional tennis referees, which players could exploit to their advantage. A relatively new rule in professional tennis allows players to challenge referee calls. As long as the player continues to challenge incorrect referee calls, the player is allowed to continue making challenges. In the 2007 Wimbledon championship, there were over 140 player challenges, and more than 25% of these resulted in overturned calls. Clearly, challenges make a difference in the outcome of tennis matches. Successfully challenging calls allows players to continue making challenges, and it therefore behooves players to challenge only those calls that they believe are clearly in error.
Although it is well known that moving objects are misperceived as being shifted in the direction of their motion ([2,3] ; see also Supplemental References in the Supplemental Data available online with this issue), these kinds of perceptual errors have rarely been documented in sports [4] [5] [6] . To measure whether referees accurately perceive the position at which a tennis ball bounces, we reviewed randomly selected Wimbledon tennis matches (4,457 total points) and recorded each case in which a tennis ball landed close to or on a line (Figure 1 ; see also the Supplemental Experimental Procedures). On each recorded trial (point), three trained observers independently rated whether the ball landed on or off the
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